ALBIREO PHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALBIREO PHARMA, INC. has filed 1,239 SEC EDGAR filings since 28 Mar 2005

SEC filing history

Showing 551-575 of 938 matching filings.

Per page
25
Current page
23
8-K File 001-33451

CURRENT REPORT

Filing date
26 May 2016
Reporting date
24 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-33451

CURRENT REPORT

Filing date
26 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-33451

FILING UNDER SECURITIES ACT RULE 425 OF CERTAIN PROSPECTUSES AND COMMUNICATIONS

Filing date
26 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

CURRENT REPORT

Filing date
25 May 2016
Reporting date
24 May 2016
Next action
Verify source filing
425 File 001-33451

CURRENT REPORT

Filing date
25 May 2016
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
01 Apr 2016
Reporting date
01 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
24 Mar 2016
Reporting date
22 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Mar 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Mar 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Mar 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Mar 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Mar 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
08 Mar 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
02 Mar 2016
Reporting date
26 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

AMENDMENT TO SC 13G

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SC 13G/A filing

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SC 13G/A filing

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SCHEDULE 13G/A

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

CURRENT REPORT

Filing date
16 Feb 2016
Reporting date
16 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SC 13G/A

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-83386

SC 13G filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83386

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .